ReviewMolecular medicine reports2026
Natural compounds for the treatment of rheumatoid arthritis based on the 'gut‑joint axis' (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease whose etiology remains incompletely understood. As the proposal and progress of the 'mucosal origin hypothesis', the role of the 'gut‑joint axis' mechanism in the pathological process of RA is gradually being revealed. Changes in the intestinal microbiota, damage to the mucosal barrier, mucosal immune dysfunction and disorders of microbial‑derived metabolites all regulate the occurrence and development of RA. Natural compounds, bioactive entities isolated from natural sources, have demonstrated distinct therapeutic advantages across a broad spectrum of diseases. The intestine may be the key for these compounds to exert their therapeutic effects on diseases. The present review summarized the 'gut‑joint axis' in RA and the natural compounds that exert therapeutic effects via this pathway. It emphasized that improving intestinal microecology may be a potential treatment method for RA, and natural compounds are expected to become promising treatment strategies for RA in this way. However, there are still numerous problems that need to be urgently solved to complete the clinical transformation of these natural compounds.2.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.